Cargando…
Postmenopausal estrogen and progestin effects on the serum proteome
BACKGROUND: Women's Health Initiative randomized trials of postmenopausal hormone therapy reported intervention effects on several clinical outcomes, with some important differences between estrogen alone and estrogen plus progestin. The biologic mechanisms underlying these effects, and these d...
Autores principales: | Pitteri, Sharon J, Hanash, Samir M, Aragaki, Aaron, Amon, Lynn M, Chen, Lin, Busald Buson, Tina, Paczesny, Sophie, Katayama, Hiroyuki, Wang, Hong, Johnson, Melissa M, Zhang, Qing, McIntosh, Martin, Wang, Pei, Kooperberg, Charles, Rossouw, Jacques E, Jackson, Rebecca D, Manson, JoAnn E, Hsia, Judith, Liu, Simin, Martin, Lisa, Prentice, Ross L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808737/ https://www.ncbi.nlm.nih.gov/pubmed/20034393 http://dx.doi.org/10.1186/gm121 |
Ejemplares similares
-
Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling
por: Prentice, Ross L, et al.
Publicado: (2010) -
Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings
por: Katayama, Hiroyuki, et al.
Publicado: (2009) -
Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases
por: Prentice, Ross L, et al.
Publicado: (2013) -
Modeling the Annual Costs of Postmenopausal Prevention Therapy: Raloxifene, Alendronate, or Estrogen-Progestin Therapy
por: Mullins, C. Daniel, et al.
Publicado: (2003) -
Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women
por: Dogiparthi, Anuradha, et al.
Publicado: (2010)